Zenarestat -: Treatment of diabetic neuropathy aldose reductase inhibitor

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [1] The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathy in Zucker diabetic fatty rats
    Shimoshige, Y
    Ikuma, K
    Yamamoto, T
    Takakura, S
    Kawamura, I
    Seki, J
    Mutoh, S
    Goto, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (11): : 1395 - 1399
  • [2] Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat
    Kihara, M
    Mitsui, Y
    Shioyama, M
    Hasegawa, T
    Takahashi, M
    Takakura, S
    Minoura, K
    Kawamura, I
    NEUROSCIENCE LETTERS, 2001, 310 (2-3) : 81 - 84
  • [3] Symptomatic improvement in diabetic neuropathy after 12 months of therapy with zenarestat, an aldose reductase inhibitor
    Bril, V
    Ng, E
    Nwe, P
    Gogov, S
    Ngo, ML
    Skandarajah, S
    DIABETES, 2002, 51 : A518 - A519
  • [4] Epalrestat: An aldose reductase inhibitor for the treatment of diabetic neuropathy
    Ramirez, Mary Ann
    Borja, Nancy L.
    PHARMACOTHERAPY, 2008, 28 (05): : 646 - 655
  • [5] TREATMENT OF DIABETIC AUTONOMIC NEUROPATHY WITH AN ALDOSE REDUCTASE INHIBITOR
    FAES, TJC
    YFF, GA
    DEWEERDT, O
    LANTING, P
    HEIMANS, JJ
    BERTELSMANN, FW
    JOURNAL OF NEUROLOGY, 1993, 240 (03) : 156 - 160
  • [6] Enzyme specificity and tissue distribution of zenarestat, an aldose reductase inhibitor, and its relevance in the use of zenarestat as a therapeutic agent against diabetic neuropathy
    Takakura, S
    Minoura, H
    Shimoshige, Y
    Minoura, K
    Kawamura, I
    Fujiwara, T
    Saitoh, T
    Shimojo, F
    Seki, J
    Goto, T
    DRUG DEVELOPMENT RESEARCH, 2001, 54 (01) : 27 - 34
  • [7] PHARMACOKINETICS OF ZENARESTAT, AN ALDOSE REDUCTASE INHIBITOR, IN MALE AND FEMALE DIABETIC RATS
    TANAKA, Y
    SAWAMOTO, T
    SUZUKI, A
    KIMURA, T
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (04) : 677 - 681
  • [8] TOXICOKINETICS OF ZENARESTAT, AN ALDOSE REDUCTASE INHIBITOR IN ANIMALS AND MAN
    TANAKA, Y
    SHIMOJYO, H
    HATA, T
    HASHIMOTO, M
    NOGUCHI, H
    XENOBIOTICA, 1994, 24 (05) : 461 - 471
  • [9] EFFECT OF THE ALDOSE REDUCTASE INHIBITOR, PONALRESTAT, ON DIABETIC NEUROPATHY
    GILL, JS
    WILLIAMS, G
    GHATEI, MA
    HETREED, AH
    MATHER, HM
    BLOOM, SR
    DIABETES & METABOLISM, 1990, 16 (04): : 296 - 302
  • [10] TOLRESTAT - AN ALDOSE REDUCTASE INHIBITOR FOR DIABETIC PERIPHERAL NEUROPATHY
    WEINTRAUB, M
    STANDISH, R
    HOSPITAL FORMULARY, 1986, 21 (09): : 912 - &
12345